Key result
Implantable devices provide highly sensitive continuous monitoring to detect asymptomatic AF and track burden.
Why the study?
Modern implantable pacemakers with advanced algorithms can detect and characterize atrial fibrillation episodes, but their ability to pace-terminate AF and the clinical impact of these functions require evaluation.
Pacemaker AF counters may refine incidence estimates in device recipients; leaves open prospective outcome validation before guiding therapy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Israel et al. (2003) conducted a review in Atrial fibrillation. Implantable devices was evaluated. Implantable devices equipped with stored electrograms and memory functions provide highly sensitive continuous monitoring for detecting asymptomatic atrial fibrillation and assessing AF burden.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: